|
Lost
Opportunity
Close on the heels of compromises and adjustments being made by
the regulator to the SSI drug units concerning Schedule-M revision,
it is now the turn of the retail drug trade in Maharashtra to be
the recipient of a largesse granted by the state FDA.
European norms for drug
development
Dr Vipin Bihari Gupta deals with norms for drug development
in European Union in the concluding part of the articleThe European
Union (EU), an initial consortium of six countries, now consists of
25 member countries representing over half-a-billion strong consumer
base. |
